Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
The Lancet Regional Health. Western Pacific
|
October 23, 2025
Risk of cancer associated with residential exposure to asbestos insulation: updated evidence
Hsei Di Law, Mark Clements, Nina Lazarevic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2022
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes
Laura M Jacobsen, Brian N Bundy, Heba M Ismail, et al.
Environmental Health Perspectives
|
January 13, 2010
Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?
Lap Ah Tse, Ignatius Tak-sun Yu, William Goggins, et al.
The New England Journal of Medicine
|
October 29, 2015
Excess Mortality among Persons with Type 2 Diabetes
Mauro Tancredi, Annika Rosengren, Ann-Marie Svensson, et al.
The Lancet. Oncology
|
August 15, 2021
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Tobias Nordström, Andrea Discacciati, Martin Bergman, et al.
European Urology Oncology
|
May 24, 2024
Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study
Xiaoyang Du, Shuang Hao, Henrik Olsson, et al.
British Journal of Cancer
|
October 5, 2016
Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study
Edoardo Colzani, Mark Clements, Anna L V Johansson, et al.
Plos One
|
August 15, 2024
Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study
Balram Rai, Tobias Nordström, Anna Lantz, et al.
Digestive Diseases and Sciences
|
April 23, 2022
Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease
Anders Forss, Mark Clements, Pär Myrelid, et al.
Scandinavian Journal of Gastroenterology
|
April 2, 2021
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up
Anders Forss, Mark Clements, Pär Myrelid, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
The Lancet Regional Health. Western Pacific
|
October 23, 2025
Risk of cancer associated with residential exposure to asbestos insulation: updated evidence
Hsei Di Law, Mark Clements, Nina Lazarevic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2022
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes
Laura M Jacobsen, Brian N Bundy, Heba M Ismail, et al.
Environmental Health Perspectives
|
January 13, 2010
Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?
Lap Ah Tse, Ignatius Tak-sun Yu, William Goggins, et al.
The New England Journal of Medicine
|
October 29, 2015
Excess Mortality among Persons with Type 2 Diabetes
Mauro Tancredi, Annika Rosengren, Ann-Marie Svensson, et al.
The Lancet. Oncology
|
August 15, 2021
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Tobias Nordström, Andrea Discacciati, Martin Bergman, et al.
European Urology Oncology
|
May 24, 2024
Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study
Xiaoyang Du, Shuang Hao, Henrik Olsson, et al.
British Journal of Cancer
|
October 5, 2016
Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study
Edoardo Colzani, Mark Clements, Anna L V Johansson, et al.
Plos One
|
August 15, 2024
Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study
Balram Rai, Tobias Nordström, Anna Lantz, et al.
Digestive Diseases and Sciences
|
April 23, 2022
Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease
Anders Forss, Mark Clements, Pär Myrelid, et al.
Scandinavian Journal of Gastroenterology
|
April 2, 2021
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up
Anders Forss, Mark Clements, Pär Myrelid, et al.
Page
of 15